📰 Albert Roy News
Page 2 - Albert Roy News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Albert Roy. Real-time updates on events, politics, business and more.
November 22, 2022
/PRNewswire/ -- Last nights Lupus Research Alliance (LRA) Breaking Through Gala at Manhattans historic Ziegfeld Ballroom was both inspiring and successful,...
November 22, 2022
NEW YORK, Nov. 22, 2022 /PRNewswire/ -- Last nights Lupus Research Alliance (LRA) Breaking Through Gala at Manhattans historic Ziegfeld Ballroom...
November 22, 2022
/PRNewswire/ -- Last nights Lupus Research Alliance (LRA) Breaking Through Gala at Manhattans historic Ziegfeld Ballroom was both inspiring and successful,...
November 15, 2022
The Lupus Research Alliance and its affiliate Lupus Therapeutics presented data at ACR Convergence 2022 with results showing the effectiveness of a pilot peer education program called the Patient Advocates for Lupus Studies (PALS), in increasing knowledge, perception, and willingness among people with Systemic Lupus Erythematosus (SLE) to participate in clinical trials.
November 8, 2022
/PRNewswire/ -- The Lupus Research Alliance and its affiliate Lupus Therapeutics will present data at ACR Convergence 2022 with results showing the...
August 18, 2022
Also, the Ballmer Group has hired a new director of Black family economic mobility, and World Central Kitchen named two co-executives to replace Nate Mook, who has resigned.
August 11, 2022
Albert Roy has been appointed as President and Chief Executive Officer (CEO) of Lupus Research Alliance effective from September 6, 2022. Currently se
August 10, 2022
/PRNewswire/ -- The Lupus Research Alliance (LRA) is pleased to announce the appointment of Albert Roy to President and Chief Executive Officer effective...
June 10, 2022
Disease activity was reduced by treatment with either of the novel investigational agents in two separate early clinical trials, with further trials planned.
June 1, 2022
COPENHAGEN, Denmark and NEW YORK, June 1, 2022 /PRNewswire/ --The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics cong...